Tzu Chi Medical Journal

REVIEW ARTICLE
Year
: 2022  |  Volume : 34  |  Issue : 1  |  Page : 35--43

Diagnosis and treatment for normal pressure hydrocephalus: From biomarkers identification to outcome improvement with combination therapy


Pao-Hui Tseng1, Li-Kung Wu2, Yi-Cheng Wang3, Tsung-Jung Ho2, Shinn-Zong Lin3, Sheng-Tzung Tsai3 
1 Department of Neurosurgery, Hualien Tzu Chi Hospital; Department of Nursing, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation and Tzu Chi University; Institute of Medical Sciences, Tzu Chi University, Hualien, Taiwan
2 Department of Chinese Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation and Tzu Chi University, Hualien, Taiwan
3 Department of Neurosurgery, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation and Tzu Chi University, Hualien, Taiwan

Correspondence Address:
Sheng-Tzung Tsai
Department of Neurosurgery, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, 707, Section 3, Chung-Yang Road, Hualien
Taiwan

Idiopathic normal pressure hydrocephalus (iNPH), albeit characterized by gait impairment, cognitive decline, and urinary incontinence, in clinical diagnosis is poorly defined and is usually coexistent with other neurodegenerative diseases. Surgical operation with shunt implantation is the primary treatment but leads to variable outcomes. Recent studies demonstrated that the pathophysiology of iNPH may include both preceding cerebrovascular events and concomitant Alzheimer's dementia or dopaminergic degenerative neuropathology in patients' brain. These factors not only help differentiate iNPH from its mimics but also associated with the extent of symptomatic improvement after surgery. In this review, we examined these mechanisms underlying the development of iNPH and the beneficial effects of shunt surgery. Furthermore, the increasing identification and importance of biomarkers from cerebrospinal fluid and neural imaging could also predict the responsiveness of treatment. Finally, these progresses suggest that combination therapy would be necessary for iNPH treatment in the future.


How to cite this article:
Tseng PH, Wu LK, Wang YC, Ho TJ, Lin SZ, Tsai ST. Diagnosis and treatment for normal pressure hydrocephalus: From biomarkers identification to outcome improvement with combination therapy.Tzu Chi Med J 2022;34:35-43


How to cite this URL:
Tseng PH, Wu LK, Wang YC, Ho TJ, Lin SZ, Tsai ST. Diagnosis and treatment for normal pressure hydrocephalus: From biomarkers identification to outcome improvement with combination therapy. Tzu Chi Med J [serial online] 2022 [cited 2022 May 27 ];34:35-43
Available from: https://www.tcmjmed.com/article.asp?issn=1016-3190;year=2022;volume=34;issue=1;spage=35;epage=43;aulast=Tseng;type=0